IRAK1 and systemic lupus erythematosus: Furthermore, JP may inhibit the activation of peritoneal macrophages in MRL/lpr mice by downregulating the IRAK1-NF-κB signaling pathway, which may be helpful in studying the mechanisms of SLE and other proinflammatory diseases and in finding new therapeutic targets.